Dec 15, 2025 06:40AM
Nov 12, 2024 07:00AM
Oct 28, 2024 09:25AM
Oct 28, 2024 09:25AM
Sep 18, 2024 07:30AM
Sep 18, 2024 07:30AM
May 30, 2024 07:00AM Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provides Business Update
Dec 14, 2023 09:00AM
Dec 14, 2023 09:00AM
Nov 13, 2023 07:00AM
Oct 23, 2023 07:42AM
Oct 23, 2023 06:25AM
Oct 23, 2023 01:38AM
Oct 23, 2023 01:00AM Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease From Roivant
Aug 14, 2023 07:00AM
Jul 6, 2023 05:49PM
Jun 28, 2023 08:57AM
Jun 28, 2023 07:00AM
Feb 13, 2023 07:00AM
Feb 13, 2023 07:00AM
Nov 14, 2022 07:00AM Roivant Sciences Reports Financial Results for the Second Quarter Ended September 30, 2022 and Provides Business Update
Nov 14, 2022 07:00AM
Jun 28, 2022 06:11AM
Jun 28, 2022 06:10AM
Jun 28, 2022 06:10AM
Feb 14, 2022 07:00AM
Feb 14, 2022 07:00AM
Jan 18, 2022 08:00AM TandemAI Announces Expansion of Senior Leadership Team
Jan 4, 2022 08:30AM
Dec 15, 2021 04:43AM
Nov 15, 2021 07:00AM
Nov 15, 2021 07:00AM
Oct 26, 2021 08:47AM
Oct 1, 2021 08:00AM
May 3, 2021 07:01AM Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All